首页 > 最新文献

Journal of Obstetrics and Gynaecology最新文献

英文 中文
Simvastatin-loaded liposomal nanoparticles as treatment for adenomyosis in a patient-derived xenograft mouse model: a pilot study. 辛伐他汀载脂质体纳米颗粒在患者来源的异种移植小鼠模型中治疗子宫腺肌症:一项初步研究。
IF 1.2 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-05-09 DOI: 10.1080/01443615.2025.2502083
Rachel Michel, Kathleen L Vincent, Gregory W Kirschen, Massoud Motamedi, Jamal Saada, Jinping Yang, Bulent Ozpolat, Gokhan S Kilic, Mostafa A Borahay

Background: Adenomyosis is a common gynaecological condition where ectopic endometrial glands and stroma grow within the myometrium. This condition has a high clinical burden impacting those afflicted with debilitating symptoms including heavy painful periods. Simvastatin is an oral hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, typically used to treat hyperlipidaemia. Simvastatin has recently shown promise for treating gynaecological conditions such as endometriosis and uterine fibroids with nanoliposomal formulations demonstrating improved efficacy. In this pilot study, we tested simvastatin-loaded liposomal nanoparticles on xenografted adenomyosis tissues in a patient-derived mouse model.

Methods: We surgically inserted oestrogen/progesterone pellets into mice, followed by adenomyosis tissue xenografts 15 days later. Mice were then randomised into three groups: control, simvastatin, and simvastatin-loaded liposomal nanoparticles (simvastatin-NP). We quantified the changes in adenomyosis xenograft size weekly using a calliper as well as ultrasound imaging 28 days after treatment, prior to sacrifice. We also measured the proliferation of biomarker Ki67 in the xenografted tissues using immunohistochemistry after animal sacrifice.

Results: Treatment with simvastatin-NP significantly reduced volume and weight of adenomyosis xenografts while attenuating Ki67 expression when compared to the control and simvastatin groups. Conclusions: This pilot study demonstrates promising improved efficacy of simvastatin delivered via liposomal nanoparticles. However, larger studies are needed to fully explore the potential of simvastatin-NP in adenomyosis.

背景:子宫腺肌症是子宫内膜异位腺体和间质生长在子宫肌层内的一种常见妇科疾病。这种情况有很高的临床负担,影响那些患有虚弱症状的人,包括严重的疼痛期。辛伐他汀是一种口服羟甲基戊二酰辅酶A (HMG-CoA)还原酶抑制剂,通常用于治疗高脂血症。辛伐他汀最近显示出治疗妇科疾病的希望,如子宫内膜异位症和子宫肌瘤,纳米脂质体制剂显示出改善的疗效。在这项初步研究中,我们在患者来源的小鼠模型中测试了辛伐他汀负载的脂质体纳米颗粒在异种移植子宫腺肌症组织上的作用。方法:通过手术将雌激素/孕酮颗粒植入小鼠体内,15d后进行子宫腺肌症组织异种移植。然后将小鼠随机分为三组:对照组、辛伐他汀和辛伐他汀负载的脂质体纳米颗粒(辛伐他汀- np)。在治疗后28天(牺牲前),我们每周使用卡尺和超声成像量化子宫腺肌症异种移植物大小的变化。我们还使用免疫组织化学方法测量了动物牺牲后异种移植组织中生物标志物Ki67的增殖。结果:与对照组和辛伐他汀组相比,辛伐他汀- np治疗显著减少子宫腺肌症异种移植物的体积和重量,同时降低Ki67的表达。结论:这项初步研究表明,辛伐他汀通过脂质体纳米颗粒递送有希望改善疗效。然而,需要更大规模的研究来充分探索辛伐他汀- np在子宫腺肌症中的潜力。
{"title":"Simvastatin-loaded liposomal nanoparticles as treatment for adenomyosis in a patient-derived xenograft mouse model: a pilot study.","authors":"Rachel Michel, Kathleen L Vincent, Gregory W Kirschen, Massoud Motamedi, Jamal Saada, Jinping Yang, Bulent Ozpolat, Gokhan S Kilic, Mostafa A Borahay","doi":"10.1080/01443615.2025.2502083","DOIUrl":"10.1080/01443615.2025.2502083","url":null,"abstract":"<p><strong>Background: </strong>Adenomyosis is a common gynaecological condition where ectopic endometrial glands and stroma grow within the myometrium. This condition has a high clinical burden impacting those afflicted with debilitating symptoms including heavy painful periods. Simvastatin is an oral hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, typically used to treat hyperlipidaemia. Simvastatin has recently shown promise for treating gynaecological conditions such as endometriosis and uterine fibroids with nanoliposomal formulations demonstrating improved efficacy. In this pilot study, we tested simvastatin-loaded liposomal nanoparticles on xenografted adenomyosis tissues in a patient-derived mouse model.</p><p><strong>Methods: </strong>We surgically inserted oestrogen/progesterone pellets into mice, followed by adenomyosis tissue xenografts 15 days later. Mice were then randomised into three groups: control, simvastatin, and simvastatin-loaded liposomal nanoparticles (simvastatin-NP). We quantified the changes in adenomyosis xenograft size weekly using a calliper as well as ultrasound imaging 28 days after treatment, prior to sacrifice. We also measured the proliferation of biomarker Ki67 in the xenografted tissues using immunohistochemistry after animal sacrifice.</p><p><strong>Results: </strong>Treatment with simvastatin-NP significantly reduced volume and weight of adenomyosis xenografts while attenuating Ki67 expression when compared to the control and simvastatin groups. <b><i>Conclusions:</i></b> This pilot study demonstrates promising improved efficacy of simvastatin delivered via liposomal nanoparticles. However, larger studies are needed to fully explore the potential of simvastatin-NP in adenomyosis.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2502083"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12168516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143987202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing postpartum hemorrhage training by integrating case-problem based learning with simulation: a quasi experimental study. 以案例问题为基础的学习与模拟相结合,加强产后出血培训:一项准实验研究。
IF 0.9 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2024-12-26 DOI: 10.1080/01443615.2024.2443617
Yike Yang, Zhichao Guo, Xiaoyue Guo, Yangyu Zhao

Background: Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide, and effective training in PPH rescue techniques is crucial. This study aims to evaluate the effectiveness of combining case-based learning (CBL) and problem-based learning (PBL) with simulation teaching methods in improving midwifery trainees' technical proficiency in managing PPH.

Methods: This quasi-experimental study involved 76 trainees who received PPH training at Peking University Third Hospital from March to July 2023. They were divided into two groups: the control group (n = 50) followed traditional simulation training methods, and the research group (n = 26) used a combination of CBL-PBL and scenario simulation. After the training, all participants completed a theoretical examination and questionnaire to assess their satisfaction with the program and self-assessment of clinical management skills in PPH. Statistical analysis was performed using unpaired t-tests and chi-square tests to compare the groups.

Results: The combination of CBL-PBL and scenario simulation was highly satisfactory compared to traditional simulation training, significantly enhancing self-assessed skills in clinical thinking (100% vs. 61.8%, p = .03), operant skills related to PPH (100% vs. 57.4%, p < .01), relevant knowledge pertaining to PPH (100% vs. 58.7%, p < .01), and management abilities (97.1% vs. 39%, p < .01) among midwifery trainees in the research group, who also scored significantly higher on post-training assessments of PPH knowledge than control groups(91.7 ± 6.0 vs 76.0 ± 7.1, p < .01). A majority of trainees expressed a preference for regular simulation exercises (98.7%) and detailed discussions on PPH cases (93.4%) in future training sessions.

Conclusion: Combining CBL-PBL with simulation practice is a more effective teaching method for PPH management training in maternity staffs with a certain level of clinical experience, compared to traditional methods. Future studies should explore the implementation of regular PPH rescue skill training in real clinical settings to support these findings.

背景:产后出血(PPH)是全球孕产妇死亡的主要原因,有效的PPH抢救技术培训至关重要。本研究旨在评估案例学习(CBL)与问题学习(PBL)相结合的模拟教学方法对提高助产学学员管理PPH的技术熟练程度的效果。方法:对2023年3月至7月在北京大学第三医院接受PPH培训的76名学员进行准实验研究。将其分为两组,对照组(n = 50)采用传统模拟训练方法,研究组(n = 26)采用CBL-PBL与情景模拟相结合的训练方法。培训结束后,所有参与者完成了理论考试和问卷调查,以评估他们对课程的满意度和PPH临床管理技能的自我评估。采用非配对t检验和卡方检验进行统计学分析。结果:与传统模拟培训相比,CBL-PBL与情景模拟相结合的培训效果较好,临床思维自我评估技能(100% vs. 61.8%, p = .03)、PPH相关操作技能(100% vs. 57.4%, p p p p p p结论:CBL-PBL与模拟实习相结合的教学方法对具有一定临床经验的产科人员进行PPH管理培训较传统方法更有效。未来的研究应探索在实际临床环境中实施常规PPH急救技能培训,以支持这些发现。
{"title":"Enhancing postpartum hemorrhage training by integrating case-problem based learning with simulation: a quasi experimental study.","authors":"Yike Yang, Zhichao Guo, Xiaoyue Guo, Yangyu Zhao","doi":"10.1080/01443615.2024.2443617","DOIUrl":"https://doi.org/10.1080/01443615.2024.2443617","url":null,"abstract":"<p><strong>Background: </strong>Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide, and effective training in PPH rescue techniques is crucial. This study aims to evaluate the effectiveness of combining case-based learning (CBL) and problem-based learning (PBL) with simulation teaching methods in improving midwifery trainees' technical proficiency in managing PPH.</p><p><strong>Methods: </strong>This quasi-experimental study involved 76 trainees who received PPH training at Peking University Third Hospital from March to July 2023. They were divided into two groups: the control group (<i>n</i> = 50) followed traditional simulation training methods, and the research group (<i>n</i> = 26) used a combination of CBL-PBL and scenario simulation. After the training, all participants completed a theoretical examination and questionnaire to assess their satisfaction with the program and self-assessment of clinical management skills in PPH. Statistical analysis was performed using unpaired t-tests and chi-square tests to compare the groups.</p><p><strong>Results: </strong>The combination of CBL-PBL and scenario simulation was highly satisfactory compared to traditional simulation training, significantly enhancing self-assessed skills in clinical thinking (100% vs. 61.8%, <i>p</i> = .03), operant skills related to PPH (100% vs. 57.4%, <i>p</i> < .01), relevant knowledge pertaining to PPH (100% vs. 58.7%, <i>p</i> < .01), and management abilities (97.1% vs. 39%, <i>p</i> < .01) among midwifery trainees in the research group, who also scored significantly higher on post-training assessments of PPH knowledge than control groups(91.7 ± 6.0 vs 76.0 ± 7.1, <i>p</i> < .01). A majority of trainees expressed a preference for regular simulation exercises (98.7%) and detailed discussions on PPH cases (93.4%) in future training sessions.</p><p><strong>Conclusion: </strong>Combining CBL-PBL with simulation practice is a more effective teaching method for PPH management training in maternity staffs with a certain level of clinical experience, compared to traditional methods. Future studies should explore the implementation of regular PPH rescue skill training in real clinical settings to support these findings.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2443617"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142895588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic internal iliac artery balloon for caesarean in placenta accreta reduces haemoglobin drop - Retrospective comparative study. 预防性髂内动脉球囊术用于增生胎盘剖宫产可减少血红蛋白下降——回顾性比较研究。
IF 0.9 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-05-09 DOI: 10.1080/01443615.2025.2495600
Yuen Yee Yannie Chan, Ellen Lok-Man Yu, Tsz Kin Lo

Background: This study compared maternal and foetal outcomes of managing placenta accreta spectrum (PAS) disease with and without prophylactic internal iliac balloon occlusion (IIABO) at a tertiary hospital between 2002 and 2021.

Methods: This retrospective cohort study included patients with confirmed PAS disorder, comparing maternal and foetal outcomes between those who underwent IIABO before caesarean delivery and those who did not, both receiving standardised multidisciplinary care. Primary outcomes included perioperative haemoglobin drop. Secondary outcomes included estimated blood loss, transfusion rate, operative duration, ICU stay, hysterectomy rates, and newborns' Apgar scores.

Results: Thirty-one antenatally diagnosed PAS patients were analysed (IIABO n = 21, non-IIABO n = 10). Over 90% had prior caesarean deliveries. IIABO is associated with lower intraoperative haemoglobin drop (p < .001) and higher postoperative haemoglobin (p = 0.047). The linear regression model demonstrated that IIABO and classical caesarean significantly reduced intraoperative blood loss (p = 0.019). No differences were seen in operative time, ICU stay, hysterectomy rates, or newborn Apgar scores. No IIABO-related complications were reported.

Conclusion: Prophylactic IIABO during caesarean delivery for PAS is associated with less haemoglobin drop and higher postoperative haemoglobin. IIABO under local anaesthesia was feasible, possibly reducing risks tied to extended general anaesthesia. Larger studies are recommended to support the role of IIABO in PAS disorders.

背景:本研究比较了2002年至2021年间在一家三级医院进行预防性髂内球囊闭塞(IIABO)和不进行预防性髂内球囊闭塞(IIABO)治疗胎盘增生谱(PAS)疾病的母婴结局。方法:本回顾性队列研究纳入了确诊PAS障碍的患者,比较剖宫产前接受IIABO和未接受IIABO的患者的母婴结局,两组患者均接受标准化的多学科护理。主要结局包括围手术期血红蛋白下降。次要结局包括估计失血量、输血率、手术时间、ICU住院时间、子宫切除术率和新生儿Apgar评分。结果:分析了31例产前诊断PAS患者(IIABO 21例,非IIABO 10例)。超过90%的患者有过剖腹产史。IIABO与术中血红蛋白下降较低相关(p p = 0.047)。线性回归模型显示IIABO和经典剖宫产术中出血量显著减少(p = 0.019)。手术时间、ICU住院时间、子宫切除术率或新生儿Apgar评分均无差异。无iiabo相关并发症报道。结论:PAS患者剖宫产时预防性IIABO可减少血红蛋白下降和术后血红蛋白升高。局部麻醉下的IIABO是可行的,可能降低与延长全身麻醉相关的风险。建议进行更大规模的研究来支持IIABO在PAS疾病中的作用。
{"title":"Prophylactic internal iliac artery balloon for caesarean in placenta accreta reduces haemoglobin drop - Retrospective comparative study.","authors":"Yuen Yee Yannie Chan, Ellen Lok-Man Yu, Tsz Kin Lo","doi":"10.1080/01443615.2025.2495600","DOIUrl":"https://doi.org/10.1080/01443615.2025.2495600","url":null,"abstract":"<p><strong>Background: </strong>This study compared maternal and foetal outcomes of managing placenta accreta spectrum (PAS) disease with and without prophylactic internal iliac balloon occlusion (IIABO) at a tertiary hospital between 2002 and 2021.</p><p><strong>Methods: </strong>This retrospective cohort study included patients with confirmed PAS disorder, comparing maternal and foetal outcomes between those who underwent IIABO before caesarean delivery and those who did not, both receiving standardised multidisciplinary care. Primary outcomes included perioperative haemoglobin drop. Secondary outcomes included estimated blood loss, transfusion rate, operative duration, ICU stay, hysterectomy rates, and newborns' Apgar scores.</p><p><strong>Results: </strong>Thirty-one antenatally diagnosed PAS patients were analysed (IIABO <i>n</i> = 21, non-IIABO <i>n</i> = 10). Over 90% had prior caesarean deliveries. IIABO is associated with lower intraoperative haemoglobin drop (<i>p</i> < .001) and higher postoperative haemoglobin (<i>p</i> = 0.047). The linear regression model demonstrated that IIABO and classical caesarean significantly reduced intraoperative blood loss (<i>p</i> = 0.019). No differences were seen in operative time, ICU stay, hysterectomy rates, or newborn Apgar scores. No IIABO-related complications were reported.</p><p><strong>Conclusion: </strong>Prophylactic IIABO during caesarean delivery for PAS is associated with less haemoglobin drop and higher postoperative haemoglobin. IIABO under local anaesthesia was feasible, possibly reducing risks tied to extended general anaesthesia. Larger studies are recommended to support the role of IIABO in PAS disorders.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2495600"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144023828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The long noncoding RNA CCDC144NL-AS1: prognosis significance and potential biological functions in cervical carcinoma. 长链非编码RNA CCDC144NL-AS1在宫颈癌中的预后意义及潜在生物学功能
IF 0.9 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-04-08 DOI: 10.1080/01443615.2025.2463416
Xuemei Hu, Yulong Wang, Hongyu Guo, Yuzhen Guo

Background: Recent research has shown that long noncoding RNA (lncRNA) performs a critical regulatory function across multiple malignancies. The involvement of RNA in the progression of multiple human cancer types has been elucidated; however, there is limited understanding regarding the importance of the lncRNA CCDC144NL-AS1 in cervical carcinoma (CC).

Methods: CCDC144NL-AS1 expression was measured in 86 CC samples by RT-PCR. CC cell lines were engineered with CCDC144NL-AS1 overexpression using plasmid vectors, allowing for the exploration of its impact on the migration of tumour cells. Additionally, we studied how CCDC144NL-AS1 impacts epithelial-mesenchymal transition signalling, focusing on its expression levels and functional roles.

Results: CCDC144NL-AS1 expression showed a notable increase in gynaecological tumour specimens and cell lines in contrast to normal control (all p < 0.05). This expression exhibited relationships with the clinical stage (p = 0.003), histologic grade (p = 0.020), and lymph node metastasis (p = 0.013). Additionally, survival rates were found to be lower in CC patients with increased CCDC144NL-AS1 expression, as confirmed by multivariate analysis, compared to individuals with reduced expression levels (Hazard ratio = 1.960; p = 0.020). CCDC144NL-AS1 also facilitated increased cell viability and migration while triggering the EMT pathway. Xenograft models demonstrated that lower CCDC144NL-AS1 levels resulted in smaller tumours and longer survival (median survival: 43.5 vs. 35.5 days, p < 0.05).

Conclusion: CCDC144NL-AS1 significantly influences cell migration, making it a promising target for CC treatment and a valuable prognostic indicator.

背景:最近的研究表明,长链非编码RNA (lncRNA)在多种恶性肿瘤中发挥着重要的调控作用。RNA参与多种人类癌症类型的进展已被阐明;然而,对于lncRNA CCDC144NL-AS1在宫颈癌(CC)中的重要性了解有限。方法:采用RT-PCR法检测86例CC标本中CCDC144NL-AS1的表达。利用质粒载体转染CCDC144NL-AS1过表达的CC细胞系,探索其对肿瘤细胞迁移的影响。此外,我们研究了CCDC144NL-AS1如何影响上皮-间质转化信号,重点关注其表达水平和功能作用。结果:与正常对照相比,CCDC144NL-AS1在妇科肿瘤标本和细胞系中的表达(p = 0.003)、组织学分级(p = 0.020)和淋巴结转移(p = 0.013)均显著升高。此外,多变量分析证实,与表达水平较低的个体相比,CCDC144NL-AS1表达升高的CC患者的生存率较低(风险比= 1.960;p = 0.020)。CCDC144NL-AS1在触发EMT通路的同时也促进了细胞活力和迁移的增加。异种移植模型表明,较低的CCDC144NL-AS1水平导致肿瘤更小,生存期更长(中位生存期:43.5天vs. 35.5天,p)。结论:CCDC144NL-AS1显著影响细胞迁移,使其成为CC治疗的有希望的靶点和有价值的预后指标。
{"title":"The long noncoding RNA CCDC144NL-AS1: prognosis significance and potential biological functions in cervical carcinoma.","authors":"Xuemei Hu, Yulong Wang, Hongyu Guo, Yuzhen Guo","doi":"10.1080/01443615.2025.2463416","DOIUrl":"10.1080/01443615.2025.2463416","url":null,"abstract":"<p><strong>Background: </strong>Recent research has shown that long noncoding RNA (lncRNA) performs a critical regulatory function across multiple malignancies. The involvement of RNA in the progression of multiple human cancer types has been elucidated; however, there is limited understanding regarding the importance of the lncRNA CCDC144NL-AS1 in cervical carcinoma (CC).</p><p><strong>Methods: </strong>CCDC144NL-AS1 expression was measured in 86 CC samples by RT-PCR. CC cell lines were engineered with CCDC144NL-AS1 overexpression using plasmid vectors, allowing for the exploration of its impact on the migration of tumour cells. Additionally, we studied how CCDC144NL-AS1 impacts epithelial-mesenchymal transition signalling, focusing on its expression levels and functional roles.</p><p><strong>Results: </strong>CCDC144NL-AS1 expression showed a notable increase in gynaecological tumour specimens and cell lines in contrast to normal control (all <i>p</i> < 0.05). This expression exhibited relationships with the clinical stage (<i>p</i> = 0.003), histologic grade (<i>p</i> = 0.020), and lymph node metastasis (<i>p</i> = 0.013). Additionally, survival rates were found to be lower in CC patients with increased CCDC144NL-AS1 expression, as confirmed by multivariate analysis, compared to individuals with reduced expression levels (Hazard ratio = 1.960; <i>p</i> = 0.020). CCDC144NL-AS1 also facilitated increased cell viability and migration while triggering the EMT pathway. Xenograft models demonstrated that lower CCDC144NL-AS1 levels resulted in smaller tumours and longer survival (median survival: 43.5 vs. 35.5 days, <i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>CCDC144NL-AS1 significantly influences cell migration, making it a promising target for CC treatment and a valuable prognostic indicator.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2463416"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143803230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using robotic single-port vNOTES for gynaecological oncology: omentectomy in a patient with an ovarian granulosa cell tumor-a case study. 使用机器人单端口vNOTES用于妇科肿瘤:卵巢颗粒细胞瘤患者的网膜切除术-一个案例研究。
IF 1.2 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-09-07 DOI: 10.1080/01443615.2025.2556279
Chunhua Zhang, Qing Li, Fang Fang, Xiaoming Guan

Background: Robotic single-port transvaginal natural orifice transluminal endoscopic surgery (RSP-vNOTES) is an emerging minimally invasive approach that combines the advantages of robotic surgery with scarless transvaginal access. Its application in gynecologic oncology remains limited, particularly for omentectomy during ovarian cancer staging.

Methods: We present the case of a 45-year-old woman with an ovarian granulosa cell tumor (GCT) who underwent supplemental staging surgery following unilateral oophorectomy. Using a single-port robotic system via the transvaginal route, hysterectomy, right salpingo-oophorectomy, and omentectomy were performed. Key technical steps included enhanced visualization with gauze placement and use of an additional robotic arm for omental traction.

Results: The procedure lasted 2 hours and 10 minutes with an estimated blood loss of 50 mL. No intraoperative or postoperative complications occurred. The patient did not require postoperative analgesics and was discharged on postoperative day 3. Final pathology confirmed absence of omental metastasis.

Conclusion: This case demonstrates the feasibility and safety of RSP-vNOTES for omentectomy in gynecologic oncology. The technique offers potential benefits including reduced abdominal trauma, faster recovery, and superior visualization for complex dissections. While further studies are necessary to validate long-term oncologic outcomes, RSP-vNOTES may represent a promising minimally invasive option for selected patients requiring ovarian cancer staging surgery.

背景:机器人单孔经阴道自然孔腔内窥镜手术(RSP-vNOTES)是一种新兴的微创手术,它结合了机器人手术和无疤痕经阴道通道的优点。它在妇科肿瘤的应用仍然有限,特别是在卵巢癌分期期间的网膜切除术。方法:我们提出的情况下,45岁的妇女与卵巢颗粒细胞瘤(GCT)谁接受补充分期手术后单侧卵巢切除术。采用单孔机器人系统经阴道行子宫切除术、右侧输卵管卵巢切除术和网膜切除术。关键的技术步骤包括通过放置纱布和使用额外的机械臂进行网膜牵引来增强可视化。结果:手术持续2小时10分钟,估计失血量为50 mL,无术中或术后并发症发生。患者不需要术后镇痛药,于术后第3天出院。最终病理证实无网膜转移。结论:本病例证明了RSP-vNOTES在妇科肿瘤大网膜切除术中的可行性和安全性。该技术提供了潜在的好处,包括减少腹部创伤,更快的恢复,以及对复杂解剖的优越可视化。虽然需要进一步的研究来验证长期的肿瘤学结果,但RSP-vNOTES可能为需要卵巢癌分期手术的特定患者提供了一种有前途的微创选择。
{"title":"Using robotic single-port vNOTES for gynaecological oncology: omentectomy in a patient with an ovarian granulosa cell tumor-a case study.","authors":"Chunhua Zhang, Qing Li, Fang Fang, Xiaoming Guan","doi":"10.1080/01443615.2025.2556279","DOIUrl":"10.1080/01443615.2025.2556279","url":null,"abstract":"<p><strong>Background: </strong>Robotic single-port transvaginal natural orifice transluminal endoscopic surgery (RSP-vNOTES) is an emerging minimally invasive approach that combines the advantages of robotic surgery with scarless transvaginal access. Its application in gynecologic oncology remains limited, particularly for omentectomy during ovarian cancer staging.</p><p><strong>Methods: </strong>We present the case of a 45-year-old woman with an ovarian granulosa cell tumor (GCT) who underwent supplemental staging surgery following unilateral oophorectomy. Using a single-port robotic system via the transvaginal route, hysterectomy, right salpingo-oophorectomy, and omentectomy were performed. Key technical steps included enhanced visualization with gauze placement and use of an additional robotic arm for omental traction.</p><p><strong>Results: </strong>The procedure lasted 2 hours and 10 minutes with an estimated blood loss of 50 mL. No intraoperative or postoperative complications occurred. The patient did not require postoperative analgesics and was discharged on postoperative day 3. Final pathology confirmed absence of omental metastasis.</p><p><strong>Conclusion: </strong>This case demonstrates the feasibility and safety of RSP-vNOTES for omentectomy in gynecologic oncology. The technique offers potential benefits including reduced abdominal trauma, faster recovery, and superior visualization for complex dissections. While further studies are necessary to validate long-term oncologic outcomes, RSP-vNOTES may represent a promising minimally invasive option for selected patients requiring ovarian cancer staging surgery.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2556279"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction. 修正。
IF 1.2 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-09-24 DOI: 10.1080/01443615.2025.2561494
{"title":"Correction.","authors":"","doi":"10.1080/01443615.2025.2561494","DOIUrl":"https://doi.org/10.1080/01443615.2025.2561494","url":null,"abstract":"","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2561494"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145131119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Life's Essential 8 and mortality in urinary incontinence among US female adults. 美国成年女性尿失禁与生命要素8与死亡率之间的关系
IF 0.9 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-06-04 DOI: 10.1080/01443615.2025.2512774
Xiaoping Xu, Ruiqian Liu

Background: Urinary incontinence (UI) may be associated with cardiovascular disease. Life's Essential 8 (LE8), a recently updated measure of cardiovascular health (CVH), has been investigated for its association with all-cause and cardiovascular mortality among US female adults with UI.

Methods: This population-based retrospective cohort study utilised data from 6314 US female adults aged ≥20 years with UI (weighted population: 4.14 million) derived from the National Health and Nutrition Examination Survey (NHANES) 2005-2018, along with their linked mortality data up to December 2019. The LE8 metric, ranging from 0 to 100, was categorised into low, moderate, and high levels. UI status was determined by self-report. Multivariable Cox proportional hazards regression models were employed to assess the associations between LE8 and both all-cause and cardiovascular disease (CVD) mortality. A stratified analysis and sensitivity analysis were also conducted.

Results: During a median follow-up period of 92 months (with a maximum of 180 months) among US adult females with UI, 684 all-cause deaths were recorded, including 169 deaths attributable to cardiovascular disease. A 10-point increase in the LE8 score was associated with a 14% reduction in the risk of all-cause mortality (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.79-0.93) and a 17% reduction in the risk of CVD mortality (HR, 0.83; 95% CI, 0.71-0.97). Physical activity has the most significant effect. In the stratified subgroups and sensitivity analyses, the results remained robust.

Conclusions: An elevated LE8 score was independently correlated with reduced risks of all-cause and cardiovascular mortality among US female adults with UI. Future prospective studies are required to further strengthen our findings.

背景:尿失禁可能与心血管疾病有关。Life's Essential 8 (LE8)是最近更新的心血管健康(CVH)指标,研究了其与美国女性尿失尿患者全因死亡率和心血管死亡率的关系。方法:这项基于人群的回顾性队列研究利用了2005-2018年国家健康与营养检查调查(NHANES)中6314名年龄≥20岁的美国女性UI(加权人口:414万)的数据,以及截至2019年12月的相关死亡率数据。LE8指标的范围从0到100,分为低、中、高三个级别。UI状态由自我报告确定。采用多变量Cox比例风险回归模型评估LE8与全因和心血管疾病(CVD)死亡率之间的关系。并进行分层分析和敏感性分析。结果:在92个月(最长180个月)的中位随访期间,美国成年女性尿失禁患者记录了684例全因死亡,其中169例死于心血管疾病。LE8评分每增加10分,全因死亡风险降低14%(风险比[HR], 0.86;95%可信区间[CI], 0.79-0.93),心血管疾病死亡风险降低17% (HR, 0.83;95% ci, 0.71-0.97)。体育锻炼的效果最为显著。在分层亚组和敏感性分析中,结果仍然稳健。结论:LE8评分升高与美国女性尿失禁患者全因死亡率和心血管死亡率降低独立相关。未来的前瞻性研究需要进一步加强我们的发现。
{"title":"Association between Life's Essential 8 and mortality in urinary incontinence among US female adults.","authors":"Xiaoping Xu, Ruiqian Liu","doi":"10.1080/01443615.2025.2512774","DOIUrl":"https://doi.org/10.1080/01443615.2025.2512774","url":null,"abstract":"<p><strong>Background: </strong>Urinary incontinence (UI) may be associated with cardiovascular disease. Life's Essential 8 (LE8), a recently updated measure of cardiovascular health (CVH), has been investigated for its association with all-cause and cardiovascular mortality among US female adults with UI.</p><p><strong>Methods: </strong>This population-based retrospective cohort study utilised data from 6314 US female adults aged ≥20 years with UI (weighted population: 4.14 million) derived from the National Health and Nutrition Examination Survey (NHANES) 2005-2018, along with their linked mortality data up to December 2019. The LE8 metric, ranging from 0 to 100, was categorised into low, moderate, and high levels. UI status was determined by self-report. Multivariable Cox proportional hazards regression models were employed to assess the associations between LE8 and both all-cause and cardiovascular disease (CVD) mortality. A stratified analysis and sensitivity analysis were also conducted.</p><p><strong>Results: </strong>During a median follow-up period of 92 months (with a maximum of 180 months) among US adult females with UI, 684 all-cause deaths were recorded, including 169 deaths attributable to cardiovascular disease. A 10-point increase in the LE8 score was associated with a 14% reduction in the risk of all-cause mortality (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.79-0.93) and a 17% reduction in the risk of CVD mortality (HR, 0.83; 95% CI, 0.71-0.97). Physical activity has the most significant effect. In the stratified subgroups and sensitivity analyses, the results remained robust.</p><p><strong>Conclusions: </strong>An elevated LE8 score was independently correlated with reduced risks of all-cause and cardiovascular mortality among US female adults with UI. Future prospective studies are required to further strengthen our findings.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2512774"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144216194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between 1400 metabolites and subtypes of endometriosis: a two-sample Mendelian randomisation study. 1400种代谢物与子宫内膜异位症亚型之间的关联:一项双样本孟德尔随机研究
IF 1.2 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-28 DOI: 10.1080/01443615.2025.2552402
Fei Yan, Zhouxiang Chen, Lingfeng Wu, Zongju Huang

Background: Endometriosis is a chronic inflammatory disease with a prevalence of approximately 10% in women of childbearing age. Metabolic pathways have been demonstrated by previous studies to be potential avenues for the development of new therapeutic strategies and may be used for early diagnosis of the disease. This study aimed to investigate the potential causal relationships between 1400 metabolites and various endometriosis subtypes using Mendelian randomisation (MR) analysis.

Methods: Data from a genome-wide association study were analysed. MR analysis was performed using the inverse-variance weighted, MR-Egger, and weighted-median methods, accompanied by heterogeneity testing, sensitivity analysis, and pleiotropy analysis. Metabolic-pathway enrichment analysis was conducted on the preliminarily screened differential metabolites, and colocalisation analysis was subsequently performed for exposure-outcome pairs that remained causally associated after multiple-testing correction.

Results: After multiple-testing correction, only the glycerol-to-palmitoylcarnitine (C16) ratio reduced the risk of stage 1-2 endometriosis (PFDR = 0.045; odds ratio [OR], 0.737; 95% confidence interval [CI], 0.638-0.852) and pelvic peritoneal endometriosis (PFDR = 0.039; OR, 0.721; 95% CI, 0.619-0.841). Colocalisation analysis revealed that they did not share causal variant loci at the genetic level. No reverse causal associations were found in the reverse Mendelian analysis. Metabolic pathway enrichment analysis identified major metabolic pathways, including caffeine metabolism, glutathione metabolism, arginine biosynthesis, sphingolipid metabolism, pantothenate and CoA biosynthesis, plasmalogen synthesis, and biosynthesis of unsaturated fatty acids.

Conclusions: Our study suggests potential causal relationships between metabolites and various endometriosis subtypes from an MR perspective. However, the limited number of associations that survived multiple-testing correction indicates that these findings are preliminary and require validation in larger cohorts. This exploratory analysis may contribute to advancing future research on metabolomics-based diagnosis, treatment, and prevention of endometriosis.

背景:子宫内膜异位症是一种慢性炎症性疾病,在育龄妇女中患病率约为10%。代谢途径已被先前的研究证明是开发新的治疗策略的潜在途径,并可能用于疾病的早期诊断。本研究旨在利用孟德尔随机化(MR)分析,探讨1400种代谢物与各种子宫内膜异位症亚型之间的潜在因果关系。方法:对全基因组关联研究数据进行分析。磁共振分析采用反方差加权法、MR- egger法和加权中位数法,并辅以异质性检验、敏感性分析和多效性分析。对初步筛选的差异代谢物进行代谢途径富集分析,随后对多次测试校正后仍然存在因果关系的暴露-结果对进行共定位分析。结果:经多次检验校正后,只有甘油与棕榈酰肉碱(C16)比值降低了1-2期子宫内膜异位症(PFDR = 0.045;优势比[OR], 0.737; 95%可信区间[CI], 0.638-0.852)和盆腔腹膜子宫内膜异位症(PFDR = 0.039; OR, 0.721; 95% CI, 0.619-0.841)的风险。共定位分析显示,他们在遗传水平上没有共享因果变异位点。在反向孟德尔分析中未发现反向因果关系。代谢途径富集分析确定了主要的代谢途径,包括咖啡因代谢、谷胱甘肽代谢、精氨酸生物合成、鞘脂代谢、泛酸和辅酶a生物合成、plasmalogen合成和不饱和脂肪酸的生物合成。结论:我们的研究表明,从磁共振角度来看,代谢物与各种子宫内膜异位症亚型之间存在潜在的因果关系。然而,经过多次检验校正后存活下来的关联数量有限,这表明这些发现是初步的,需要在更大的队列中进行验证。这一探索性分析可能有助于推进基于代谢组学的子宫内膜异位症的诊断、治疗和预防的未来研究。
{"title":"Associations between 1400 metabolites and subtypes of endometriosis: a two-sample Mendelian randomisation study.","authors":"Fei Yan, Zhouxiang Chen, Lingfeng Wu, Zongju Huang","doi":"10.1080/01443615.2025.2552402","DOIUrl":"https://doi.org/10.1080/01443615.2025.2552402","url":null,"abstract":"<p><strong>Background: </strong>Endometriosis is a chronic inflammatory disease with a prevalence of approximately 10% in women of childbearing age. Metabolic pathways have been demonstrated by previous studies to be potential avenues for the development of new therapeutic strategies and may be used for early diagnosis of the disease. This study aimed to investigate the potential causal relationships between 1400 metabolites and various endometriosis subtypes using Mendelian randomisation (MR) analysis.</p><p><strong>Methods: </strong>Data from a genome-wide association study were analysed. MR analysis was performed using the inverse-variance weighted, MR-Egger, and weighted-median methods, accompanied by heterogeneity testing, sensitivity analysis, and pleiotropy analysis. Metabolic-pathway enrichment analysis was conducted on the preliminarily screened differential metabolites, and colocalisation analysis was subsequently performed for exposure-outcome pairs that remained causally associated after multiple-testing correction.</p><p><strong>Results: </strong>After multiple-testing correction, only the glycerol-to-palmitoylcarnitine (C16) ratio reduced the risk of stage 1-2 endometriosis (<i>P</i><sub>FDR</sub> = 0.045; odds ratio [OR], 0.737; 95% confidence interval [CI], 0.638-0.852) and pelvic peritoneal endometriosis (<i>P</i><sub>FDR</sub> = 0.039; OR, 0.721; 95% CI, 0.619-0.841). Colocalisation analysis revealed that they did not share causal variant loci at the genetic level. No reverse causal associations were found in the reverse Mendelian analysis. Metabolic pathway enrichment analysis identified major metabolic pathways, including caffeine metabolism, glutathione metabolism, arginine biosynthesis, sphingolipid metabolism, pantothenate and CoA biosynthesis, plasmalogen synthesis, and biosynthesis of unsaturated fatty acids.</p><p><strong>Conclusions: </strong>Our study suggests potential causal relationships between metabolites and various endometriosis subtypes from an MR perspective. However, the limited number of associations that survived multiple-testing correction indicates that these findings are preliminary and require validation in larger cohorts. This exploratory analysis may contribute to advancing future research on metabolomics-based diagnosis, treatment, and prevention of endometriosis.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2552402"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstetric violence prevalence and risk factors: an umbrella review. 产科暴力发生率和风险因素:概括性审查。
IF 1.2 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-14 DOI: 10.1080/01443615.2025.2566204
Victoria Roberta Gabiati Niedo, Lucía Guinevere Lahoz Molina, Naomi Cano-Ibáñez, Nichole Waltrich, Khalid S Khan, Carmen Amezcua-Prieto

Background: Obstetric violence (OV) is a gender-based human rights violation during pregnancy, labour, and postpartum. Despite increasing recognition, the global prevalence and risk factors associated with OV remain poorly understood. We aim to estimate the prevalence of OV worldwide, examine regional disparities, and identify the associated risk factors through an umbrella review.

Methods: After prospective registration (PROSPERO CRD42025631985), a comprehensive search was conducted in PubMed, Scopus, Web of Science, and Scielo for reviews published between January 2015 and March 2025. Two reviewers independently selected studies, extracted data, and assessed methodological quality using the AMSTAR 2 tool. Overlap of studies among the included reviews was quantified using the corrected covered area (CCA). The risk factor data were summarised as odds ratio (OR) with 95% confidence interval (CI).

Results: Fourteen reviews, with a total of 1,116,159 participants, were included; of which 10 (71.4%) were of critically low or low quality and only one review was high quality. The CCA was very low at 1.136%. OV prevalence varied from 23.2% to 59%, depending on region and definitional criteria. Forms of OV included physical (3.1-78.4%), verbal or psychological (2.6-66%), and social (1.9-94%) mistreatment. Statistically significant risk factors included low socioeconomic status (maximum OR = 3.68; 95% CI = 1.4-9.7), obstetric complications (maximum OR = 6.41; 95% CI: 1.36-30.14), limited education (OR = 5.92; 95% CI 1.38-23.81), public healthcare births (maximum OR = 4.34; IC 95%: 1.58-11.97), instrumental delivery (OR = 2.35; 95% CI: 1.72-3.22), and inadequate provider training (OR = 1.47; 95% CI: 1.05-2.04).

Conclusions: OV is a prevalent global issue. Vulnerable populations, i.e. those with lower socioeconomic status and limited education, were more often affected. The low methodological quality of the existing literature is a key weakness. There is a need for standardised definitions and improved research validity for the development of evidence-based interventions.

背景:产科暴力(OV)是在怀孕、分娩和产后期间基于性别的人权侵犯。尽管越来越多的认识,全球患病率和与OV相关的危险因素仍然知之甚少。我们的目的是估计OV的全球患病率,检查地区差异,并通过总括性回顾确定相关的危险因素。方法:前瞻性注册(PROSPERO CRD42025631985)后,在PubMed、Scopus、Web of Science和Scielo中全面检索2015年1月至2025年3月间发表的综述。两位审稿人独立选择研究,提取数据,并使用AMSTAR 2工具评估方法学质量。使用校正覆盖面积(CCA)量化纳入综述中研究的重叠。危险因素数据汇总为95%可信区间(CI)的优势比(OR)。结果:纳入14篇综述,共计1,116,159名受试者;其中10篇(71.4%)是极低或低质量的,只有一篇是高质量的。CCA非常低,为1.136%。根据地区和定义标准,OV患病率从23.2%到59%不等。OV的形式包括身体虐待(3.1-78.4%)、言语或心理虐待(2.6-66%)和社会虐待(1.9-94%)。具有统计学意义的危险因素包括低社会经济地位(最大OR = 3.68; 95% CI = 1.4-9.7)、产科并发症(最大OR = 6.41; 95% CI: 1.36-30.14)、受教育程度有限(OR = 5.92; 95% CI: 1.38-23.81)、公共卫生保健分娩(最大OR = 4.34; IC 95%: 1.58-11.97)、器械分娩(OR = 2.35; 95% CI: 1.72-3.22)和提供者培训不足(OR = 1.47; 95% CI: 1.05-2.04)。结论:OV是一个普遍的全球性问题。弱势群体,即那些社会经济地位较低和受教育程度有限的人,更经常受到影响。现有文献的低方法学质量是一个关键的弱点。有必要对以证据为基础的干预措施进行标准化的定义和改进研究的有效性。
{"title":"Obstetric violence prevalence and risk factors: an umbrella review.","authors":"Victoria Roberta Gabiati Niedo, Lucía Guinevere Lahoz Molina, Naomi Cano-Ibáñez, Nichole Waltrich, Khalid S Khan, Carmen Amezcua-Prieto","doi":"10.1080/01443615.2025.2566204","DOIUrl":"10.1080/01443615.2025.2566204","url":null,"abstract":"<p><strong>Background: </strong>Obstetric violence (OV) is a gender-based human rights violation during pregnancy, labour, and postpartum. Despite increasing recognition, the global prevalence and risk factors associated with OV remain poorly understood. We aim to estimate the prevalence of OV worldwide, examine regional disparities, and identify the associated risk factors through an umbrella review.</p><p><strong>Methods: </strong>After prospective registration (PROSPERO CRD42025631985), a comprehensive search was conducted in PubMed, Scopus, Web of Science, and Scielo for reviews published between January 2015 and March 2025. Two reviewers independently selected studies, extracted data, and assessed methodological quality using the AMSTAR 2 tool. Overlap of studies among the included reviews was quantified using the corrected covered area (CCA). The risk factor data were summarised as odds ratio (OR) with 95% confidence interval (CI).</p><p><strong>Results: </strong>Fourteen reviews, with a total of 1,116,159 participants, were included; of which 10 (71.4%) were of critically low or low quality and only one review was high quality. The CCA was very low at 1.136%. OV prevalence varied from 23.2% to 59%, depending on region and definitional criteria. Forms of OV included physical (3.1-78.4%), verbal or psychological (2.6-66%), and social (1.9-94%) mistreatment. Statistically significant risk factors included low socioeconomic status (maximum OR = 3.68; 95% CI = 1.4-9.7), obstetric complications (maximum OR = 6.41; 95% CI: 1.36-30.14), limited education (OR = 5.92; 95% CI 1.38-23.81), public healthcare births (maximum OR = 4.34; IC 95%: 1.58-11.97), instrumental delivery (OR = 2.35; 95% CI: 1.72-3.22), and inadequate provider training (OR = 1.47; 95% CI: 1.05-2.04).</p><p><strong>Conclusions: </strong>OV is a prevalent global issue. Vulnerable populations, i.e. those with lower socioeconomic status and limited education, were more often affected. The low methodological quality of the existing literature is a key weakness. There is a need for standardised definitions and improved research validity for the development of evidence-based interventions.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2566204"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145286336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of sacral nerve magnetic stimulation in preventing urinary retention after total hysterectomy: a randomised controlled trial. 骶神经磁刺激预防全子宫切除术后尿潴留的疗效:一项随机对照试验。
IF 1.2 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-06 DOI: 10.1080/01443615.2025.2566202
Linan Chen, Shuyun Zhang, Yi Qin

Background: Urinary retention following total hysterectomy is a prevalent postoperative complication that significantly impacts patient recovery and quality of life. Current prevention methods have limitations, prompting exploration of more effective strategies. Sacral nerve magnetic stimulation (SMS), an innovative, non-invasive approach, has shown potential in managing urinary disorders.

Methods: In this single-centre, prospective, randomised controlled trial, 100 patients undergoing surgery for gynaecological malignancies were randomly assigned to receive either standard care (control group) or SMS treatment plus standard care (intervention group). The primary outcome was the incidence of post-operative urinary retention (POUR) (the number of patients with residual urine volume over 100 mL or inability to void divided by the total number of patients in each group, expressed as a percentage), with secondary outcomes including time to spontaneous voiding, re-catheterisation rate and pelvic floor muscle strength.

Results: The intervention group had a significantly lower POUR incidence (14% vs. 36%, p = .002), shorter time to spontaneous voiding (1.5 days vs. 2.5 days, p < .001) and lower re-catheterisation rate (12% vs. 30%, p = .012) compared to the control group. Pelvic floor muscle strength also improved in the intervention group (p = .03). No serious adverse events related to SMS were reported.

Conclusions: SMS can significantly reduce the incidence of POUR and shortened the time to spontaneous voiding, while also decreasing the re-catheterisation rate compared to the control group.

背景:全子宫切除术后尿潴留是一种常见的术后并发症,严重影响患者的康复和生活质量。目前的预防方法有局限性,需要探索更有效的策略。骶神经磁刺激(SMS)是一种创新的、非侵入性的治疗泌尿系统疾病的方法。方法:在这项单中心、前瞻性、随机对照试验中,100例接受妇科恶性肿瘤手术的患者被随机分配接受标准治疗(对照组)或SMS治疗加标准治疗(干预组)。主要结局是术后尿潴留(POUR)发生率(残尿量超过100 mL或无法排尿的患者数除以每组患者总数,以百分比表示),次要结局包括自然排尿时间、再导尿率和盆底肌力。结果:干预组与对照组相比,自发性排尿发生率明显降低(14% vs. 36%, p = 0.002),自然排尿时间缩短(1.5天vs. 2.5天,p = 0.012)。干预组盆底肌力也有改善(p = .03)。未报告与SMS相关的严重不良事件。结论:与对照组相比,SMS可显著降低POUR发生率,缩短自然排尿时间,同时降低再导尿率。
{"title":"Efficacy of sacral nerve magnetic stimulation in preventing urinary retention after total hysterectomy: a randomised controlled trial.","authors":"Linan Chen, Shuyun Zhang, Yi Qin","doi":"10.1080/01443615.2025.2566202","DOIUrl":"10.1080/01443615.2025.2566202","url":null,"abstract":"<p><strong>Background: </strong>Urinary retention following total hysterectomy is a prevalent postoperative complication that significantly impacts patient recovery and quality of life. Current prevention methods have limitations, prompting exploration of more effective strategies. Sacral nerve magnetic stimulation (SMS), an innovative, non-invasive approach, has shown potential in managing urinary disorders.</p><p><strong>Methods: </strong>In this single-centre, prospective, randomised controlled trial, 100 patients undergoing surgery for gynaecological malignancies were randomly assigned to receive either standard care (control group) or SMS treatment plus standard care (intervention group). The primary outcome was the incidence of post-operative urinary retention (POUR) (the number of patients with residual urine volume over 100 mL or inability to void divided by the total number of patients in each group, expressed as a percentage), with secondary outcomes including time to spontaneous voiding, re-catheterisation rate and pelvic floor muscle strength.</p><p><strong>Results: </strong>The intervention group had a significantly lower POUR incidence (14% vs. 36%, <i>p</i> = .002), shorter time to spontaneous voiding (1.5 days vs. 2.5 days, <i>p</i> < .001) and lower re-catheterisation rate (12% vs. 30%, <i>p</i> = .012) compared to the control group. Pelvic floor muscle strength also improved in the intervention group (<i>p</i> = .03). No serious adverse events related to SMS were reported.</p><p><strong>Conclusions: </strong>SMS can significantly reduce the incidence of POUR and shortened the time to spontaneous voiding, while also decreasing the re-catheterisation rate compared to the control group.</p>","PeriodicalId":16627,"journal":{"name":"Journal of Obstetrics and Gynaecology","volume":"45 1","pages":"2566202"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145232937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Obstetrics and Gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1